|
13 Jun 2018 |
Social |
Lindstrom studied their Swedish AS registry and found that While the presence of Uveitis was assoc w/ better TNFi responses; all other comorbidities yielded lesser TNFi responses. #EULAR2018 @RheumNow OP0023 https://t.co/bltRC4khbL |
|
|
13 Jun 2018 |
Social |
RT @DrPetryna: #EULAR18 @RheumNow ABST op0028 BCD-085, novel humanised monoclonal IL-17 Ab w/ genetically modified Fc- and CDR-regions sho… |
|
|
02 Jun 2018 |
Social |
RheumNow Wk in Review is up. Good news for GPA and Renal transplant, Early RA challenges, Vaccinots and HPV and the risk of cancer in PsA. Check out the podcast https://t.co/nqif5yPBx9 or the website video https://t.co/bj6ar7ZlYT |
|
|
31 May 2018 |
News |
MRI Imaging for Sacroiliitis Requires Bone Marrow Edema for Reliability |
|
|
29 May 2018 |
Social |
UCB announces the FDA has approved Cimzia (certolizumab) for use in moderate to severe plaque psoriasis based on over 1000 pts in Phase 3 RCTs CIMPASI-1, CIMPASI-2 and CIMPACT and PASI75 of 75-82% at wk16 https://t.co/PYx15htd3Z |
|
|
29 May 2018 |
Social |
Certolizumab is now FDA approved for use in Crohns disease, Rheumatoid arthritis, Ankylosing spondylitis, psoriatic arthritis and now Psoriasis.https://t.co/QVpmv7V9PI |
|
|
29 May 2018 |
News |
Cancer Risk Raised in Psoriatic Arthritis |
|
|
17 May 2018 |
News |
Trends in Psoriatic Arthritis Treatment 2004-2015 |
|
|
14 May 2018 |
News |
Ankylosing Spondylitis Women Show Less Durable Responses to TNF Inhibitors |
|
|
14 May 2018 |
Slide of the day |
Rare Risk of Colitis with IL-17 Inhibitors |
|
|
13 May 2018 |
Social |
RT @NatRevRheumatol: Our new #Review is online!
Gladman and colleagues highlight the similarities and differences between #AnkylosingSpondy… |
|
|
03 May 2018 |
News |
Targeting IL-17A: A Winner in PsA |
|
|
01 May 2018 |
News |
Comorbidities Undermine Clinical Outcomes in Psoriatic Arthritis |
|
|
30 Apr 2018 |
Social |
April meeting of European Medicines Agency, the Committee for Medicinal Products for Human Use (CHMP) recommended the approval of new indications for CIMZIA- certolizumab pegol (for plaque psoriasis) and XELJANZ-tofacitinib (for psoriatic arthritis). https://t.co/W4A0AIyZ80 |
|
|
19 Apr 2018 |
Social |
RT @LCalabreseDO: Anxiously await PHASE 3 Tocilizumab PSS study. The extension is provocative. Toxicity will be key based on effect size ht… |
|
|
10 Apr 2018 |
News |
Apremilast in DMARD-Naive Psoriatic Arthritis |
|
|
07 Apr 2018 |
Social |
RT @emartinmola: Most PsA patients discontinue initial biologic within 12 months https://t.co/KxfWR4IsNn |
|
|
04 Apr 2018 |
Social |
Study of 114 kids with enthesitis related JIA shows axial Dz/sacroiliitis rare at onset but after mean of 2.6 yrs found in 63% and 47% respectively. + Familiy Hx of SpA associated w/ sacroiliitis (OR = 3.6) & active disease (OR 3.0) at last FUV https://t.co/xRQhm6iGA6 |
|
|
03 Apr 2018 |
Blog |
The Delayed Diagnosis of Spondyloarthritis |
|
|
01 Apr 2018 |
Social |
Survey of 442 Dutch axial SpA patients finds Hidradenitis suppurativa twice as common (9.1% vs 4.1%) in AxSpA - HS/AxSpA more likely female with higher ASAS & BASDAI scores w/ more dactylitis & enthesitis. https://t.co/yJeyIr5uiM |
|
